Drugs / TA-NIC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00633321 | May 2007 → Dec 2008 | — | Celtic Pharma Development Services | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TA-NIC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00633321 ↗ |
| Modality | Vaccine | “TA-NIC vaccine” NCT00633321 ↗ |